These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 16168678)
1. Measurement of 5-HT4 receptor-mediated esophageal responses by digital sonomicrometry in the anesthetized rat. Armstrong SR; McCullough JL; Beattie DT J Pharmacol Toxicol Methods; 2006; 53(3):198-205. PubMed ID: 16168678 [TBL] [Abstract][Full Text] [Related]
2. The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo. Beattie DT; Smith JA; Marquess D; Vickery RG; Armstrong SR; Pulido-Rios T; McCullough JL; Sandlund C; Richardson C; Mai N; Humphrey PP Br J Pharmacol; 2004 Nov; 143(5):549-60. PubMed ID: 15466450 [TBL] [Abstract][Full Text] [Related]
3. The 5-HT2B antagonist and 5-HT4 agonist activities of tegaserod in the anaesthetized rat. McCullough JL; Armstrong SR; Hegde SS; Beattie DT Pharmacol Res; 2006 Apr; 53(4):353-8. PubMed ID: 16495076 [TBL] [Abstract][Full Text] [Related]
4. The in vivo gastrointestinal activity of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity. Beattie DT; Armstrong SR; Shaw JP; Marquess D; Sandlund C; Smith JA; Taylor JA; Humphrey PP Naunyn Schmiedebergs Arch Pharmacol; 2008 Jul; 378(1):139-47. PubMed ID: 18408918 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological properties of a novel gastrointestinal prokinetic benzamide selective for human 5-HT4 receptor versus human 5-HT3 receptor. Nagakura Y; Akuzawa S; Miyata K; Kamato T; Suzuki T; Ito H; Yamaguchi T Pharmacol Res; 1999 May; 39(5):375-82. PubMed ID: 10328995 [TBL] [Abstract][Full Text] [Related]
6. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro. Mine Y; Yoshikawa T; Oku S; Nagai R; Yoshida N; Hosoki K J Pharmacol Exp Ther; 1997 Dec; 283(3):1000-8. PubMed ID: 9399969 [TBL] [Abstract][Full Text] [Related]
7. SC-53606, a potent and selective antagonist of 5-hydroxytryptamine4 receptors in isolated rat esophageal tunica muscularis mucosae. Yang DC; Goldstin B; Moormann AE; Flynn DL; Gullikson GW J Pharmacol Exp Ther; 1993 Sep; 266(3):1339-47. PubMed ID: 8396633 [TBL] [Abstract][Full Text] [Related]
8. Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs. Nagakura Y; Kamato T; Nishida A; Ito H; Yamano M; Miyata K Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):489-98. PubMed ID: 8740141 [TBL] [Abstract][Full Text] [Related]
9. Comparison of 5-HT4 receptors in guinea-pig colon and rat oesophagus: effects of novel agonists and antagonists. Leung E; Pulido-Rios MT; Bonhaus DW; Pekins LA; Zeitung KD; Hsu SA; Clark RD; Wong EH; Eglen RM Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):145-56. PubMed ID: 8857591 [TBL] [Abstract][Full Text] [Related]
10. 5-HT4 receptor-mediated modulation of 5-HT release in the rat hippocampus in vivo. Ge J; Barnes NM Br J Pharmacol; 1996 Apr; 117(7):1475-80. PubMed ID: 8730742 [TBL] [Abstract][Full Text] [Related]
11. Neural 5-HT4 receptors in the human isolated detrusor muscle: effects of indole, benzimidazolone and substituted benzamide agonists and antagonists. Candura SM; Messori E; Franceschetti GP; D'Agostino G; Vicini D; Tagliani M; Tonini M Br J Pharmacol; 1996 Aug; 118(8):1965-70. PubMed ID: 8864530 [TBL] [Abstract][Full Text] [Related]
12. GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor. Gale JD; Grossman CJ; Whitehead JW; Oxford AW; Bunce KT; Humphrey PP Br J Pharmacol; 1994 Jan; 111(1):332-8. PubMed ID: 8012715 [TBL] [Abstract][Full Text] [Related]
13. Identification of SK-951, a novel benzofuran derivative, as an agonist to 5-HT4 receptors. Takeda M; Tsukamoto K; Mizutani Y; Suzuki T; Taniyama K Jpn J Pharmacol; 1999 Feb; 79(2):203-12. PubMed ID: 10202856 [TBL] [Abstract][Full Text] [Related]
15. Effects of 5-HT1A and 5-HT4 receptor agonists on slow synaptic potentials in enteric neurons. Pan H; Galligan JJ Eur J Pharmacol; 1995 May; 278(1):67-74. PubMed ID: 7664814 [TBL] [Abstract][Full Text] [Related]
16. Effects of mosapride on esophageal secondary peristalsis in humans. Chen CL; Liu TT; Yi CH; Orr WC Neurogastroenterol Motil; 2011 Jul; 23(7):606-e249. PubMed ID: 21501334 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-2,3-dihydro-2-oxo-1 H- benzimidazole-1-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine4 receptor in the tunica muscularis mucosae of rat esophagus and ileum of guinea pig: role of endogenous 5-hydroxytryptamine. Waikar MV; Hegde SS; Ford AP; Clarke DE J Pharmacol Exp Ther; 1993 Feb; 264(2):654-61. PubMed ID: 8437113 [TBL] [Abstract][Full Text] [Related]
18. Effects of 5-HT4-receptor agonists, cisapride, mosapride citrate, and zacopride, on cardiac action potentials in guinea pig isolated papillary muscles. Kii Y; Ito T J Cardiovasc Pharmacol; 1997 May; 29(5):670-5. PubMed ID: 9213211 [TBL] [Abstract][Full Text] [Related]
19. Further investigation into the signal transduction mechanism of the 5-HT4-like receptor in the circular smooth muscle of human colon. McLean PG; Coupar IM Br J Pharmacol; 1996 Jun; 118(4):1058-64. PubMed ID: 8799582 [TBL] [Abstract][Full Text] [Related]
20. A comparative study of functional 5-HT4 receptors in human colon, rat oesophagus and rat ileum. McLean PG; Coupar IM; Molenaar P Br J Pharmacol; 1995 May; 115(1):47-56. PubMed ID: 7647983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]